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Challenges and diagnosis of isolated 
left ventricular non-compaction: A case 
series of 4 patients with echocardio-
graphic diagnosis of possible ILVNC
DIAGNOSIS 
OF ILVNC
This case series describes the clinical and echocardiographic 
features of patients with trabeculations consistent with ILVNC, 
in the setting of potential alternative aetiologies for heart failure. 
There are challenges and pitfalls in the diagnosis of ILVNC with 
transthoracic echocardiogram (TTE) as a single modality, and all 
suspected cases should be confirmed with cardiac magnetic 
resonance imaging (CMRI).
CASE REPORTS
We describe the clinical features and echocardiographic findings 
of 4 patients seen on referral in the period 2011 - 2014, with a 
possible diagnosis of ILVNC, based on the echocardiographic 
criteria proposed by Jenni, et al.(6) at Universitas Academic 
Hospital in Bloemfontein, South Africa. CMRI was not per-
formed on any of these patients. Consent to publish these 
case reports was obtained from the patients – and the Ethics 
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Left ventricular non-compaction (LVNC) is a rare disorder that 
has been described as a primary genetic cardiomyopathy by 
the American Heart Association,(1) and an “unspecified” cardio-
myopathy by the European Society of Cardiology.(2) Non-
compacted myocardium can occur in association with intra-
myocardial sinusoids and other complex congenital heart 
lesions – such as right or left ventricular flow tract obstruction, 
complex cyanotic heart lesions and coronary anomalies.(3,4) 
In contrast, isolated left ventricular non-compaction (ILVNC) is 
an idiopathic cardiomyopathy resulting from intra-uterine 
arrest of the normal myocardial morphogenesis from the 
epicardial to the endocardial side, in the absence of other 
cardiac lesions.(5) It is characterised by excessive trabeculations 
of the ventricular wall, with inter-trabecular recesses that are in 
communication with the left ventricular cavity. The excessive 
trabeculation of the ventricular wall is also referred to as 
“spongy myocardium”.(4) Trabeculations have been reported 
in 68% of normal hearts, but these are usually three or less 
in number, although the diameter can be more than 2mm.(5) 
The age of presentation and onset of symptoms vary greatly. 
Patients with ILVNC usually present with heart failure, 
thrombo-embolism and arrhythmias – with heart failure being 
the most common reason for referral for echocardiography.(5)
Isolated left ventricular non-compaction (ILVNC) is a 
rare, congenital, idiopathic cardiomyopathy that may 
present in adulthood. There is no true gold standard 
for the diagnosis of ILVNC. Two-dimensional echo-
cardiography with colour Doppler is the modality of 
choice to diagnose the condition. However, the diagnosis 
should be confi rmed with cardiac magnetic resonance 
imaging (CMRI), as well as either a positive family 
history, complications of ILVNC or confi rmatory genetic 
testing. We describe the clinical and echocardiographic 
features in 4 patients, each with a possible diagnosis of 
ILVNC, in the setting of potential alternative aetiologies 
for heart failure. Approval to present these cases was 
obtained from the institutional ethics committee and 
the patients also provided consent. Suffi cient trans-
thoracic echocardiographic (TTE) evidence of ILVNC 
according to previously published criteria was found in 
all the cases, although it was not confi rmed with CMRI. 
This case series highlights the importance of routine 
echocardiography in all patients who present with heart 
failure – irrespective of associated risk factors. We 
caution against over-diagnosis of ILVNC with TTE alone, 
and recommend the use of CMRI as a second-line 
diagnostic investigation. Screening of family members 
and prevention of complications of confi rmed cases of 













FIGURE 2: Apical 4 chamber view of Case 3, showing 
trabeculations in the apex of the left ventricular wall.
TABLE I: Summary of patients’ demographic information, and clinical and echocardiographic features.
Age 
(years) Gender Ethnicity Clinical and echocardiographic features
Case 1 59 Male African Long-standing hypertension. Presented with peripheral oedema, and class II NYHA dyspnoea.
Echocardiography showed LV non-compaction with prominent trabeculae in the LV apex. LVEF 24%, 
LVEDD 7.3cm, LVESD 6.3cm
Case 2 16 Male African Prior diagnosis of anthracycline-induced cardiomyopathy. Asymptomatic.
LVEF 30% with global hypokinesia and severe non-compaction of LV free wall and apex. LVEDD 6.3cm, 
LVESD 5.2cm.
Case 3 37 Female African Presented with symptoms of heart failure, 2 months post-partum, and diagnosed with post-partum 
cardiomyopathy.
LVEF 18% with trabeculation of LV apex and free wall. LVEDD 5.6cm, LVESD 5.2cm
Case 4 48 Male African History of alcohol abuse. Presented with chest pain and palpitations ,with an “irregular pulse”. 
Echocardiography showed severe trabeculations from mid-to-apical region. “Smoke”* observed in LV; 
LVEF 24%.
NYAH = New York Heart Association, LV = left ventricle, LVEF = left ventricular ejection fraction, LVEDD = left ventricular end-diastolic dimension, LVESD = left ventricular 
end-systolic dimension. *“Smoke” refers to spontaneous echocardiographic contrast (SEC).
Committee of the Faculty of Health Sciences, University of 
the Free State (ECUFS 234/2015), approved publication. The 
patients’ clinical features and demographic information are 
summarised in Table I.
Case 1
A 59-year-old male patient with a long-standing history of 
hypertension, presented with class II New York Heart 
Association (NYHA) dyspnoea and bilateral pitting oedema. 
Echocardiographic findings revealed a left ventricular ejection 
fraction of 24% with a markedly trabeculated left ventricle.
Case 2
A 16-year-old male patient with a history of a skin tumor as a 
four-year-old, and treated with an anthracycline-based regimen. 
He developed heart failure with reduced ejection fraction at 
age 5, and was diagnosed and treated as anthracycline
-induced cardiomyopathy with good clinical response. He 
defaulted follow-up at age 12 and represented at age of 16, still 
asymptomatic. Echocardiography was performed showing left 
ventricular ejection fraction (LVEF) of 56%, and the diagnosis of 
ILVNC was made based on the TTE findings. His ejection 
fraction deteriorated over the following 3 years to 24%, with 
severe LVNC visible on echocardiography, as shown in Figure 1. 
At the most recent follow-up, he was still asymptomatic and on 
warfarin and anti-failure treatment.
Case 3
A 37-year-old female patient who presented with NYHA class 
IV dyspnoea, which started two months postpartum. She was 
FIGURE 1: Echocardiography of Case 2. 
Short-axis view showing trabeculations in the left ventricular wall, 
with inter-trabecular recesses in continuation with the left ven-
tricular cavity.
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referred for echocardiography due to refractory heart failure. 
She had no family history of cardiac disease and no features of 
embolic phenomena. TTE showed an LVEF of 18% with 
trabeculations of the apex of the left ventricle (Figures 2, 3 & 4), 
consistent with criteria proposed by Jenni, et al.(6) for the 
diagnosis of ILVNC. No thrombi were documented on echo-
cardiography.
Case 4
A fit, 48-year-old male patient with a history of alcohol abuse, 
presented with typical angina chest pain and palpitations, 
without symptoms of heart failure. An electrocardiogram 
(ECG) was performed, which showed a narrow complex 
tachycardia, no P waves in standard lead II and V1, deeply 
inverted T waves in all leads, and Sokolow-Lyon voltage criteria 
for left ventricular hypertrophy (Figure 5). He was admitted to 
the coronary care unit and treated with adenosine and later 
intravenous amiodarone. The ECG immediately following 
amiodarone showed a bigeminal rhythm with inverted T waves 
in all leads. Normal coronary arteries were found on angio-
graphy. He later developed sinus bradycardia with deep 
inverted T waves and left ventricular hypertrophy. A subsequent 
24-hour holter ECG showed no dysrhythmia. Although lost to 
follow-up, a family member reported that he was still alive and 
well without treatment, and chose to terminate follow-up. His 
echocardiographic findings are presented in Figures 6 and 7.
DISCUSSION
During early foetal life, at approximately 5 - 8 weeks of embry-
onic development, the myocardium is a network of muscle 
fibres separated by deep recesses that are in connection with 
the left ventricular cavity. As embryonic life continues, the 
process of compaction occurs from the epicardium to the 
endocardium, and from the base of the heart to the apex.(4) 
The coronary circulation develops during the same time and 
the recesses are reduced to capillaries. Ventricular non-com-
paction is a result of altered intra-uterine compaction of the 
myocardium.
ILVNC can be sporadic or familial. Familial recurrence of 
ILVNC can be autosomal dominant, X-linked or mitochondrial 
in origin. Genetic heterogeneity within this disorder has been 
reported, and a number of mutations are recognised to cause 
ILVNC; however, no single gene abnormality has been des-
cribed.(7) Major genetic mutations in ILVNC and their asso-
ciation with other cardiomyopathies have been described.(4,8) 
In 2013, Esposito, et al.(8) reported the first, and to our know-
ledge, the only case of LVNC associated with congenital fibre 
type disproportion (CFTD) in an Italian family. Two novel genes 
have been described, with their synergistic effect resulting in 
a severe disease phenotype.(8) Despite the fact that ILVNC 
is a congenital condition, it may present in adulthood.(5,9-11) 
It is recommended that a meticulous three-generational family 
history be obtained to evaluate for genetic influence, as a 
positive family history has an impact on screening of other 
family members.(12) Follow-up of family members of an index 
case has identified a 30% familial occurrence.(13) Between 60% 
and 70% of cases of ILVNC are sporadic. The Heart Rhythm 
Society has made a Class I recommendation that genetic testing 
be performed on relatives when a specific gene has been 
identified.(14)
There is no true gold standard for the diagnosis of ILVNC. 
Diagnostic criteria are still evolving and standardised diagnostic 
criteria have not yet been established.(7,15) It is important to 
note that there is a risk of over-interpretation of trabeculations 
DIAGNOSIS OF ILVNC
FIGURE 3: Short axis view of Case 3.
FIGURE 4: Transoesophageal echocardiogram (TOE) 














Compared to non-compaction, trabeculations in normal hearts 
run from the free wall to the septum, while in ILVNC the 
trabeculations do not involve the septum.(7) In dilated cardio-
myopathy and hypertensive heart disease, the ratio of the 
trabeculated to the non-trabeculated layer is 0.8 and 1.1, 
respectively.(6) Normal trabeculation of the left ventricle is 
prominent in black African patients compared to white patients, 
and has the phenotypical appearance of ILVNC, without the 
presence of left ventricular disease.(10) Two-dimensional echo-
cardiography with colour Doppler is the modality of choice 
on TTE. Prominent trabeculations may be part of normal hearts, 
and may be prominent in athletes and African patients. 
Pathological conditions such as dilated cardiomyopathy, apical 
hypertrophic cardiomyopathy (HCM), and peri-partum cardio-
myopathy, in patients recovering from myocarditis and hyper-
tensive heart disease, may mimic ILVNC. Peri-partum cardio-
myopathy may be a more suitable diagnosis than ILVNC in 
Case 3 and Case 4, and could be apical HCM. CMRI might have 
been useful to differentiate ILVNC from other aetiologies of 
hypertrabeculation.
FIGURE 6: Short-axis echocardiographic views of 
Case 4, showing trabeculations.
FIGURE 7: Short-axis views of Case 4, showing flow 
within the trabeculations from within the left ventricle.
FIGURE 5: ECG findings of Case 4 at presentation.
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for the diagnosis of ILVNC,(16) and is considered a first-line 
investigation. TTE is safe, non-invasive, cost-effective and readily 
available in most facilities in developing countries. It is unknown 
which diagnostic echocardiographic (morphologic) criteria are 
most sensitive and specific.(15) 
Echocardiographic criteria have been proposed for the diag-
nosis of ILVNC,(6) and our institution uses the criteria published 
by Jenni, at al.,(6) as summarised in Table II. The application of 
these echocardiographic criteria allows some differentiation 
between ILVNC and ILVNC mimickers. There is inaccuracy in 
evaluating compacted versus non-compacted myocardium with 
oblique image planes or off-axis images. Standard chamber 
views must be obtained, and contrast may be used to improve 
imaging of the apex. 
Cardiac magnetic resonance imaging (CMRI) is a second-line 
investigation used to support a TTE diagnosis of ILVNC, and 
can better differentiate compacted and non-compacted myo-
cardium. Unlike TTE, CMRI is not dependent on specific views, 
and allows the whole ventricle to be visualised rather than 
segments. The apical, anterior, anterolateral and lateral aspects 
of the ventricle are better visualised using CMRI.(16,17) Specific 
diagnostic criteria (Table III) have been established for the diag-
nosis of ILVNC on CMRI.(18,19)
Despite better imaging, CMRI is not an ideal investigation; 
availability is limited, and it requires expertise to interpret. 
Furthermore, some patients may have metal implants/devices 
that limit CMRI use. In addition, the investigation takes time and 
requires a patient who can lie supine and be able to cooperate 
with breath-holding, which may be difficult in patients with 
symptomatic heart failure. False positive results may occur in 
asymptomatic patients.(20) Garcia-Pavia, et al.(21) have suggested 
that the criteria in Table 4 are applied to make a definitive 
diagnosis of ILVNC.
The prevalence of ILVNC is unknown, and echocardiographic 
studies have reported a prevalence of 0.014% - 1.3%,(7,11) and 
the diagnosis may often be missed. A number of cases have 
been reported from Africa,(9,22-26) including South Africa.(10,22) 
At a cardiomyopathy clinic in Johannesburg, the prevalence of 
ILVNC was 6.9%, and the diagnosis was based on echo-
cardiographic criteria alone.(10) 
The myocardial segments predominantly affected according to 
TTE performed in our case series, were the apex (50%) and 
the lateral wall (50%). None of our patients presented with 
inferior wall involvement, which was contrary to other published 
studies where the inferior wall was predominantly affected in 
more than 74% of cases.(3,5,10,11) This suggests that alternate 
DIAGNOSIS OF ILVNC
TABLE II: Echocardiographic diagnostic criteria compiled 
from Jenni, et al.(6)
Diagnostic criteria Echocardiographic notes
Compacted epicardial layer and non-
compacted endocardial layer with prominent 
trabeculae and deep inter-trabecular recesses
Short axis view; 
end-systole




Segmental hypokinesia and non-compaction 
involving mainly the mid-lateral wall, and 
apical and mid-inferior wall
End-systole
Evidence of forward blood fl ow from 
ventricular cavity to inter-trabecular recesses 
throughout the cardiac cycle
Colour Doppler
Absence of co-existing cardiac anomalies
TABLE IV: Criteria for diagnosis of ILVNC, as suggested 
by Garcia-Parvia, et al.(21)
1:  Patient must fulfi ll quantitative short-axis diagnostic 
criteria on both of the following: 
• Echocardiography (Jenni(6) criteria) and
• Cardiac magnetic resonance imaging (Jacquier(17) criteria)
2: Patient must have at least 1 of the following features:
• LVNC diagnosed in another family member;
• Regional wall motion abnormalities;
•  ILVNC-related complications (arrhythmia, heart failure, or 
thromboembolism); or
•  A carrier of a pathogenic mutation in a gene previously associated with 
LVNC in various families, or novel disease-causing mutations using 
next-generation sequencing techniques and validation of these 
mutations in experimental disease models.
TABLE III: Cardiac magnetic resonance imaging (CMRI) 
criteria for ILVNC.
Author CMRI Criteria
Petersen, et al.(19) Pathological non-compacted myocardium to 
compacted myocardium >2.3 during end-diastole 
predictive of ILVNC.
(sensitivity = 86%, specifi city = 99%).
Jacquier, et al.(17) Trabeculated left ventricular mass >20% of global 
ventricular mass is predictive of ILVNC. 













diagnoses should be considered in our patients, and supports 
the need for CMRI and applying the criteria proposed by 
Garcia-Pavia, et al.(21) (Table IV) to confirm or exclude a 
diagnosis of ILVNC. 
The clinical presentation of patients reported ranges from 
asymptomatic to disabling refractory heart failure. In asymp-
tomatic patients, non-compaction may occur as an incidental 
finding on echocardiography, and ILVNC may be found in 
patients with unexplained heart failure. Symptomatic patients 
with ILVNC usually present with heart failure, arrhythmias or 
embolic phenomena.(8)  
The thrombo-embolic features in patients with NCLV can be 
attributed to thrombus formation in the inter-trabecular 
recesses, combined with the hypokinetic myocardium and 
systolic dysfunction. In previous studies, thrombo-embolic com-
plications were reported at a frequency of 9% - 38%.(3,5,11,24) 
There is no agreement about anticoagulation therapy in patients 
with LVNC. Some authors favour the use of anticoagulation 
agents in patients with non-compaction, regardless of the 
patient’s history of thrombosis.(3,4,6,7) Visible thrombus and atrial 
fibrillation are definite indications for anticoagulation. The 
CHADS2/CHA2DS2-VASc score may be used in patients with 
reduced ejection fractions in the absence of atrial fibrillation, to 
guide anticoagulation in cases of confirmed ILVNC.(27) 
The frequency of arrhythmias in ILVNC varies between 14% 
and 63% in published case series,(3,5,11,24) and occurred in 1.8% of 
patients with LVNC in a previous South African study.(10) The 
mortality rate in Oechslin's cohort(3) was 35%, with sudden 
cardiac death and heart failure responsible for 50% and 33%, 
respectively, of all deaths.(3) The histologic and autopsy findings 
of fibrosis and scarring can theoretically explain the arrhyth-
mogenicity of the myocardium.(4,6) 
ILVNC during pregnancy has been reported.(6) However, de 
novo left ventricular trabeculations may be found in a significant 
number of asymptomatic pregnant women as a result of 
increased pre-load and physiologic response to pregnancy, and 
then resolve later.(28) A diagnosis of ILVNC should thus not be 
made in the peri-partum period. 
CONCLUSION
We describe 4 cases of possible ILVNC, a low prevalence 
disease, based on TTE findings, in the setting of alternative 
aetiologies for heart failure. Echocardiography is the standard 
test for diagnosis; however, if suggestive of ILVNC, CMRI 
should be performed to rule out or confirm the disease. In the 
case of confirmed ILVNC, genetic consultation and testing of 
family members are necessary. 
We recommend that even in resource-poor settings such as 
ours, all patients presenting with clinical signs and symptoms of 
heart failure should be referred for TTE. However, we caution 
against over-diagnosis of ILVNC using echocardiographic 
criteria alone. African patients, athletes and peri-partum 
patients, may have increased trabeculations that may be 
physiological. 
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